The Healthy Alaskan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Healthy Alaskan.

Press releases published on April 2, 2026

Apr. 2, 2026

Global Flexible PCB Market to Nearly Double, Reaching $41.7 Billion by 2030 on Surging Demand from Consumer Electronics, EVs and 5G Infrastructure

Indeterminate GlobeNewswire

Apr. 2, 2026

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk

Indeterminate GlobeNewswire

Apr. 2, 2026

Sienna Announces First Quarter 2026 Results Release Date and Conference Call

Indeterminate GlobeNewswire

Apr. 2, 2026

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

Indeterminate GlobeNewswire

Apr. 2, 2026

Protecting Healthy Futures: Unity Consortium Urges Families to Prioritize Adolescent Health During Immunization Action Week

Indeterminate GlobeNewswire

Apr. 2, 2026

Dr. Joseph Mikhael Steps into New Role as Medical Advisor for the International Myeloma Foundation

Indeterminate GlobeNewswire

Apr. 2, 2026

Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds

Indeterminate GlobeNewswire

Apr. 2, 2026

Catalyst MedTech Announces Acquisition of X3D

Indeterminate GlobeNewswire

Apr. 2, 2026

PracticeLink Reveals Evolved Brand Identity Focused on Clarity, Simplicity and Trust for Healthcare Providers and Recruiters

Indeterminate GlobeNewswire

Apr. 2, 2026

Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies

Indeterminate GlobeNewswire

Apr. 2, 2026

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Indeterminate GlobeNewswire

Apr. 2, 2026

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

Indeterminate GlobeNewswire

Apr. 2, 2026

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Indeterminate GlobeNewswire

Apr. 2, 2026

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Indeterminate GlobeNewswire

Apr. 2, 2026

Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform

Indeterminate GlobeNewswire

Apr. 2, 2026

Sienna Completes Acquisition in Greater Toronto Area

Indeterminate GlobeNewswire

Apr. 2, 2026

Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems

Indeterminate GlobeNewswire

Apr. 2, 2026

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Indeterminate GlobeNewswire

Apr. 2, 2026

MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member

Indeterminate GlobeNewswire

Apr. 2, 2026

Picard Medical / SynCardia COO to Deliver Keynote at Venture Café Phoenix During Arizona Tech Week

Indeterminate GlobeNewswire